Latest Headlines

31. Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing 1/22/2026

    Mikart, a leading Contract Development and Manufacturing Organization (CDMO) specializing in small-molecule pharmaceutical products, proudly celebrates its 50th anniversary. Since its founding in 1975, Mikart has been dedicated to delivering innovative solutions, quality manufacturing, and outstanding service to its clients in the pharmaceutical industry.

32. Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta 1/22/2026

    Mikart, a leading contract development and manufacturing organization (CDMO), today announced that it has signed a lease for new headquarters space at the Cumberland Center II, a premier office tower in the Cumberland-Galleria region of Northwest Atlanta. The newly leased facility, encompassing approximately 13,000 square feet, will house Mikart’s administrative and corporate functions.

33. Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility 1/22/2026

    Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North Carolina manufacturing facility. The increased investment will more than double the total commitment for the company’s first-ever East Coast manufacturing facility to approximately $2 billion.

34. CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion 1/20/2026

    Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of advanced laboratory services.

35. Wilmington PharmaTech Appoints Seasoned Commercial Leader To Drive Growth 1/16/2026

    Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has appointed Mike Shearer to the role of Chief Commercial Officer, where he will play a pivotal role in driving growth, strengthening client partnerships, and furthering the organization’s position as a trusted partner for API development and manufacturing. Shearer will report to Hui-Yin “Harry” Li, Ph.D., WPT’s Founder and CEO.

36. Coating Place Secures Growth Capital Investment By 1315 Capital 1/16/2026

    Coating Place, a leading U.S.-based contract development and manufacturing organization (CDMO), has secured a strategic, growth investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm.

37. INTERPHEX Opens Registration For 2026 With Expanded Show Floor, Education And Debut Of New Contract & Outsourcing Hub 1/14/2026

    INTERPHEX, the premier pharmaceutical and biotechnology event returns to NYC, taking place April 21 – 23 at the Javits Center. Representing the full scope of the pharmaceutical value chain, INTERPHEX continues to be the event to discover breakthrough solutions that enhance manufacturing, development, regulatory compliance and supply chain efficiency to support the evolving industry.

38. AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services 1/14/2026

    The acquisition of the Tempe, Arizona facility will expand U.S.-based drug delivery device capacity and support the company’s $10 billion manufacturing investment.

39. Johnson & Johnson Announces Plans For New Manufacturing Facilities In North Carolina And Pennsylvania 1/13/2026

    Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The joint agreement meets the requests laid out by President Trump to the industry and provides the Company’s pharmaceutical products an exemption from tariffs.

40. Sharp Sterile Manufacturing Increases Capacity With $28 Million Investment Featuring New IMA Isolated Vial Filling Line 1/8/2026

    Sharp Sterile Manufacturing has today announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly skilled engineering and pharmaceutical manufacturing roles within the local life sciences community and represents a major milestone in Sharp Sterile’s development.